Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.

NCT05888701 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05888701
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05888701 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
"Don't Eat me" Signal in Hematological Malignancies: CD24 as New Target to Improve Anti-cancer Immunity.
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Unknown status
Start date
September 8, 2022
Completion date
December 31, 2024
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

b cell chronic lymphocytic leukemia, mantle-cell lymphoma